Company Analysis

Shoulder Innovations, Inc. (SI)

NYSE: SI · Surgical & Medical Instruments & Apparatus · Grand Rapids, MI · filing with the SEC since 2017
Grade5.3
◀ Past 5.0● Present 5.5▶ Future 5.1
5 est.

Who owns Shoulder Innovations, Inc.

As filed with the SEC
Holders of 5% or more
5
Fmr LLC holds 17.7% of COMMON STOCK, as its SCHEDULE 13G/A filed Aug 6, 2026 says.
Directors and officers
12
report now, of 12 people on the record since 2025. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G/A · filed Aug 6, 2026 · COMMON STOCK · 19% in Sep 8, 2025
17.7%
Casey M. Tansey
SCHEDULE 13G · filed Nov 14, 2025 · Common Stock, par value $0.001 per share
13.3%
Gilde Healthcare Holding B.V.
SCHEDULE 13D/A · filed Aug 7, 2026 · Common Stock, $0.001 par value per share · 11.8% in Aug 5, 2025
10.7%
LSV Associates II, LLC
SCHEDULE 13G · filed Nov 14, 2025 · Common Stock, par value $0.001 per share
9.3%
Arboretum Ventures VI, L.P.
SCHEDULE 13G · filed Aug 8, 2025 · Common Stock, $0.001 par value per share
5.8%
Ball Robert Joseph
SCHEDULE 13G/A · filed May 7, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.7% in Nov 12, 2025
under 5%
What SI reports owning in othersstakes of 5% or more, and other ties
Shoulder Innovations, Inc. reports no stake in another company in the record.
Insider tradesForm 4
7sales
7purchases
6sales on a scheduled plan
2people selling
$1.0Msold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Nov 2, 2025 to Nov 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2526
2026 runs to Nov 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 18 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Gilde Healthcare Holding B.V.10% owner10$4.4M00$0
Ahearn Matthew FraserChief Operating Officer6$800,00060$0
Ball Robert JosephCEO & Executive Chairman1$200,00003$100,000
Points Jeffrey S.Chief Financial Officer0$003$100,000
Buchholz Richarddirector0$001$0
SI Assistanton SI · research, not advice